Cardiovascular Research Foundation

Cardiovascular Research Foundation
Name	Cardiovascular Research Foundation
Formation	1970s
Type	Nonprofit research organization
Headquarters	New York City
Leader title	President
Leader name	Dr. Dominic J. Sisti

Cardiovascular Research Foundation is a nonprofit organization based in New York City dedicated to translational research, clinical innovation, and professional education in interventional cardiology and structural heart disease. It organizes landmark meetings, sponsors multicenter clinical trials, and operates training programs that bridge academic centers such as Columbia University and NewYork-Presbyterian Hospital with community hospitals and industry partners like Medtronic, Boston Scientific, and Abbott Laboratories. The foundation has influenced practice guidelines from bodies including the American College of Cardiology, the American Heart Association, and the European Society of Cardiology.

History

Founded during the era of rapid growth in cardiac catheterization, the organization emerged contemporaneously with institutions such as Mount Sinai Hospital and Johns Hopkins Hospital that advanced percutaneous techniques. Early collaborations linked investigators from Massachusetts General Hospital, Cleveland Clinic, and Mayo Clinic to pioneers in angioplasty like Andreas Grüntzig and leaders associated with the National Institutes of Health. The foundation expanded through the 1980s and 1990s alongside development of stent technology pioneered by researchers connected to Palmaz-Schatz designs and later drug-eluting platforms influenced by teams at Stanford University and University of California, San Francisco. In the 21st century the foundation played roles parallel to initiatives at European Heart Journal-affiliated groups and multinational consortia around trials such as those coordinated with Duke University and Imperial College London.

Mission and Programs

The foundation’s stated mission aligns with the objectives of clinical innovators and academic departments at institutions like Harvard Medical School, Yale School of Medicine, and University of Pennsylvania Perelman School of Medicine: to translate device and pharmacologic advances into improved patient outcomes. Programs include investigator-initiated networks that mirror cooperative groups such as CARDIoGRAM and trial infrastructure resembling operations of Cooperative Studies Program units at Veterans Affairs Medical Center. Educational outreach connects to societies like the Society for Cardiovascular Angiography and Interventions and the European Association of Percutaneous Cardiovascular Interventions.

Research and Clinical Trials

The organization sponsors randomized trials, registries, and real-world evidence initiatives often partnered with academic cores at Columbia University Irving Medical Center and laboratory collaborators at Massachusetts Institute of Technology. Trials have assessed technologies related to transcatheter aortic valve replacement pathways developed by teams at NHS England centers and transcatheter mitral therapies emerging from collaborations with University of Zurich investigators. Its registries have contributed data comparable to projects led by National Cardiovascular Data Registry and consortia involving Johns Hopkins Bloomberg School of Public Health. Device evaluation programs mirror regulatory science methods seen at U.S. Food and Drug Administration interactions and international regulatory counterparts such as European Medicines Agency.

Education and Training

Fellowship and proctoring activities engage trainees and faculty from Weill Cornell Medicine, Rutgers University, and University of Toronto. Hands-on courses use models influenced by simulation centers at Cleveland Clinic Lerner College of Medicine and curriculum structures similar to those at Mayo Clinic College of Medicine and Science. Mentorship connects early-career investigators to senior faculty with profiles like those at University of California, San Diego and Northwestern University Feinberg School of Medicine, and to global educators from Karolinska Institutet and Peking University.

Conferences and Publications

The foundation organizes high-profile meetings that attract presenters from journals and editorial boards such as The Lancet, New England Journal of Medicine, JAMA, European Heart Journal, and Circulation. Conference formats resemble sessions established by Heart Rhythm Society and World Congress of Cardiology gatherings, showcasing late-breaking trial results, live case transmissions, and consensus panels that include contributors from Royal Brompton Hospital and Mount Sinai School of Medicine. Its proceedings and white papers are disseminated alongside professional periodicals edited by scholars from Oxford University Press and publishers working with Wiley.

Funding and Partnerships

Financial support derives from philanthropic sources, competitive grants, and collaborative agreements with corporations such as Edwards Lifesciences, Siemens Healthineers, and Philips Healthcare. Research funding models are analogous to those employed by Bill & Melinda Gates Foundation-supported consortia and by university-industry partnerships at Stanford School of Medicine. Strategic alliances extend internationally to centers affiliated with Aarhus University Hospital, Tel Aviv Sourasky Medical Center, and Seoul National University Hospital.

Awards and Recognition

The foundation and its staff have received awards and citations from professional organizations including the American College of Cardiology Foundation, the European Society of Cardiology prize committees, and honors bestowed by entities like The Society of Thoracic Surgeons. Individual investigators affiliated with the foundation have been recipients of career development awards similar to NIH R01-level recognition and prizes named by institutions such as Johns Hopkins University and University College London.

Category:Cardiology organizations